Enorama Pharma AB is a Swedish pharmaceutical company based in Malmö, with a fully owned US subsidiary in Florida. The company has since 2016 been listed on Nasdaq First North Growth Market in Stockholm. Enorama Pharma is focusing on the development and manufacturing of consumer-friendly, oral nicotine products, such as nicotine white pouches under the brand name NIC-S® and nicotine chewing gum (medicinal).
| Website | http://www.enoramapharma.com |
| Revenue | $4 million |
| Employees | 8 (7 on RocketReach) |
| Founded | 2006 |
| Address | Västra Varvsgatan 19, Malmö, Skåne County 211 77, SE |
| Phone | +46 40 14 06 20 |
| Industry | Pharmaceutical Manufacturing, Drug Stores & Pharmacies, Retail |
| Web Rank | 8 Million |
| Keywords | Pharmaceutical, Health Technology, Drug Development, Clinical Trials, Therapeutics, Biotechnology, Fda Approval, Pharmaceutical Sales, Drug Discovery, Pharma Research, Prescription Drugs, Healthcare, Medical Research, Biopharma, Pharmaceutical Manufacturing, Drug Formulation, Clinical Research, Regulatory Affairs, Drug Patents |
| Competitors | AstraZeneca, Amgen, Eisai Co., Ltd., Alkermes, Altria, Kraton Polymers Research B.V., Fate Therapeutics Inc, PharmaJet, XenoPort, Inc., Opiant Pharmaceuticals +35 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Enorama Pharma employee's phone or email?
The Enorama Pharma annual revenue was $4 million in 2026.
Jonas Brisland is the CFO of Enorama Pharma.
7 people are employed at Enorama Pharma.
Enorama Pharma is based in Malmö, Skåne County.
The NAICS codes for Enorama Pharma are [3254, 32541, 32, 325].
The SIC codes for Enorama Pharma are [28, 283].